Tacrolimus, Sirolimus and Ustekinumab vs. Tacrolimus and Sirolimus for the Prevention of Acute Graft-Versus-Host Disease
Clinical trial NCT01713400 · COMPLETED
Trial details
- NCT number
- NCT01713400
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-25
- Primary completion
- 2014-10-27
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.